Home › Funds › Sio Capital Management, LLC › GMED
Sio Capital Management, LLC position in GMED
GLOBUS MED INC · Health Care
Sio Capital Management, LLC reported holding 301,816 shares of GMED (GLOBUS MED INC) in its Q2 2026 13F filing — a position valued at US$23.8M, representing 3.95% of its reported portfolio and ranking #5 among its reported holdings. Sio Capital Management, LLC has disclosed GMED holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sio Capital Management, LLC's GMED position evolved
Sio Capital Management, LLC first disclosed a stake in GMED in Q3 2023 at 516,981 shares (US$25.7M). The position peaked in Q4 2023 at 532,089 shares, worth US$28.4M. Across 6 filings, Sio Capital Management, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 301,816 shares valued at US$23.8M. Notable position changes include a 26% trim in Q1 2024 (shares rose 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 516.98K | $25.67M | New |
| Q4 2023 | 532.09K | $28.36M | Add |
| Q1 2024 | 393.42K | $21.10M | Reduce |
| Q1 2025 | 207.00K | $15.15M | New |
| Q2 2025 | 245.57K | $14.49M | Add |
| Q2 2026 | 301.82K | $23.85M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMED and 13F data
GMED (GLOBUS MED INC) is a Health Care company. 39 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$124.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMED
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4.28M sh · $338.14M · Q2 2026
- Sculptor Capital LP 3.00M sh · $237.03M · Q2 2026
- Boston Trust Walden Corp 1.57M sh · $124.31M · Q2 2026
- GW&K Investment Management, LLC 1.45M sh · $114.82M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.42M sh · $111.96M · Q2 2026
- Madison Avenue Partners, LP 935.22K sh · $73.89M · Q2 2026
- ANTIPODES PARTNERS Ltd 905.98K sh · $71.58M · Q2 2026
- PARADIGM CAPITAL MANAGEMENT INC/NY 886.50K sh · $70.04M · Q2 2026
More on Sio Capital Management, LLC
FAQ
How long has Sio Capital Management, LLC held GMED?
Sio Capital Management, LLC has disclosed GMED holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
What is Sio Capital Management, LLC's current position in GMED?
As of Q2 2026, Sio Capital Management, LLC holds 301.82K shares of GMED (GLOBUS MED INC), valued at $23.85M, representing 3.95% of its reported portfolio and ranking #5.
Has Sio Capital Management, LLC been buying or selling GMED?
In the latest 13F filing (Q2 2026), Sio Capital Management, LLC newly opened its position in GMED. The position peaked in Q4 2023 at 532.09K shares.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.